bpc 157 peptide cons BPC-157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven BPC-157 – Research Peptide |

If you take a high dose (1,000 mcg), your body absorbs only about 1% of it (NIH-a, 2021)

The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide

Arcan P, Bozkurt O, Cavusoglu D, Gencpnar P, Haspolat S, Duman O, Olgac Dundar N

This is a somewhat unexpected result, although for SOC density and similar the values at higher depth are also significantly lower, so possibly this is why the errors are also in average lower even though models are typically based on much fewer points than what is available for top-soil